5,6-Dimethyl-2-(pyridin-3-yl)-1H-benzo[d]imidazole

Catalog No.: 
ACUWQB215
CAS No.: 
6507-10-4
Molecular Formula: 
C14H13N3
Molecular Weight: 
223.28
5,6-Dimethyl-2-(pyridin-3-yl)-1H-benzo[d]imidazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$231.00InquiryInquiry
1g97%$521.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5,6-Dimethyl-2-(pyridin-3-yl)-1H-benzo[d]imidazole
IUPAC Name5,6-dimethyl-2-(pyridin-3-yl)-1H-benzo[d]imidazole
MDL No.MFCD11912414
Molecular FormulaC14H13N3
Molecular Weight223.28
SMILESCC1=C(C)C=C2C(NC(C3=CC=CN=C3)=N2)=C1
InChI KeyUXTQYKZDUKVADS-UHFFFAOYSA-N
Synonym5,6-dimethyl-2-(pyridin-3-yl)-1H-benzo[d]imidazole;1H-Benzimidazole, 5,6-dimethyl-2-(3-pyridinyl)-
CAS No.6507-10-4
PubChem CID39158296

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACUWQB215 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYPKO420 route compound structure diagram
    ACYPKO4203171-45-7In Stock
  2. Plus
  3. ACIGKT215 route compound structure diagram
    ACIGKT21559-67-6In Stock
  4. Then
  5. ACUWQB215 route product structure diagram
    ACUWQB2156507-10-4
Inquiry

2. ACUWQB215 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYPKO420 route compound structure diagram
    ACYPKO4203171-45-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUWQB215 route product structure diagram
    ACUWQB2156507-10-4
Inquiry

3. ACUWQB215 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUWQB215 route product structure diagram
    ACUWQB2156507-10-4
Inquiry

Comments (0)